Panelists discuss several promising new agents for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including an LPA1 receptor antagonist showing lung function ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback